Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials.
about
A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspectiveComparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analyExperiences of mobility for people living with rheumatoid arthritis who are receiving biologic drug therapy: implications for podiatry services.Use of "spydergrams" to present and interpret SF-36 health-related quality of life data across rheumatic diseasesThe use of biologic DMARDs identifies rheumatoid arthritis patients with more optimistic expectations of total knee arthroplasty.Role and rationale for the use of milnacipran in the management of fibromyalgiaThe loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study.Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegolPatterns of disease-modifying antirheumatic drug use in rheumatoid arthritis patients after 2002: a systematic review.Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized contPatient-reported outcomes and the association with clinical response in patients with active psoriatic arthritis treated with golimumab: findings through 2 years of a phase III, multicenter, randomized, double-blind, placebo-controlled trial.Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trialReceipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plansCoverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D.Are changes in glycaemic control associated with diabetes-specific quality of life and health status in screen-detected type 2 diabetes patients? Four-year follow up of the ADDITION-Cambridge cohortMilnacipran: a selective serotonin and norepinephrine dual reuptake inhibitor for the management of fibromyalgiaDo rheumatologists know best? An outcomes study of inconsistent users of disease-modifying anti-rheumatic drugsPerioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview.
P2860
Q26770099-8D338D6C-CC48-421D-95B8-CE1F3CA5C760Q27694496-12678C24-A9DB-4384-B902-20F6073E3BEBQ30842186-879B36BC-E9B0-4A05-82BE-D583B56616B0Q33515869-2F25128F-97CA-44F7-9660-8F6F6AA33AE0Q33808559-7C2D96FD-F989-42E4-85A6-515F1468A056Q33881505-A642299C-C420-4C5B-B749-4FD6573CADE5Q33923245-909341FE-BEBB-4AAE-A212-8985DB49382DQ34117111-4F7332E1-AE51-48D0-A832-F2E1BA7FFE16Q34379235-9EBA1D60-8606-4A1B-AD3B-7E130AE220A6Q34413310-AFB346D7-3D64-48F1-B413-FB82C085E4B5Q34803148-907B8F41-899D-4417-A461-3AA5E83F9DABQ34905646-53CD19A4-A796-41FC-9156-6259AEA873C1Q35212433-517ACD2B-907A-40F0-8FE6-0A64F1B624D2Q35731438-F8F65134-F796-4666-8BD6-FF03D202C1FCQ35870194-E1D64E15-42E1-445A-8FBC-3717182AE6EAQ36059500-F0C634F5-EE25-46A8-B21B-ADEB717F9B8BQ36830635-39A4A789-9B7B-4A25-BE79-B29177E68A62Q52349399-C51909DF-3663-4AB8-9D45-2BB5C6A96B93
P2860
Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Improved health-related qualit ...... randomized controlled trials.
@en
Improved health-related qualit ...... randomized controlled trials.
@nl
type
label
Improved health-related qualit ...... randomized controlled trials.
@en
Improved health-related qualit ...... randomized controlled trials.
@nl
prefLabel
Improved health-related qualit ...... randomized controlled trials.
@en
Improved health-related qualit ...... randomized controlled trials.
@nl
P1476
Improved health-related qualit ...... m randomized controlled trials
@en
P2093
Jasvinder A Singh
Vibeke Strand
P304
P577
2008-04-01T00:00:00Z